Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: The REST (RLS epidemiology, symptoms, and treatment) primary care study

Sleep Medicine

Volumn 5, Issue 3, 2004, Pages 237-246

  Hening, Wayne ^a,h   Walters, Arthur S ^a,b,c   Allen, Richard P ^d   Montplaisir, Jacques ^e   Myers, Andrew ^f   Ferini Strambi, Luigi ^g  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b NEW JERSEY NEUROSCIENCE INSTITUTE   (United States)

^c SETON HALL UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f Premark Services   (United Kingdom)

^g VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^h NONE   (United States)

Author keywords

Insomnia; Prevalence; Primary care; Quality of life; Restless legs syndrome; Sleep disturbance

Indexed keywords

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; DICLOFENAC; GABAPENTIN; LEVODOPA; PARACETAMOL; QUININE DERIVATIVE; RESTEX; THIOCOLCHICOSIDE; TRAZODONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EXHAUSTION; FATIGUE; FEMALE; FOLLOW UP; FRANCE; GENERAL PRACTITIONER; GERMANY; HEALTH SURVEY; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MUSCLE TWITCH; POPULATION RESEARCH; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RESTLESS LEGS SYNDROME; SCREENING; SLEEP DISORDER; SOMNOLENCE; SPAIN; SYMPTOMATOLOGY; UNITED KINGDOM; UNITED STATES;

DRUG THERAPY; FRANCE; GERMANY; GREAT BRITAIN; HUMANS; PREVALENCE; PRIMARY HEALTH CARE; QUALITY OF LIFE; QUESTIONNAIRES; RESTLESS LEGS SYNDROME; SPAIN; UNITED STATES;

EID: 2542490412     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2004.03.006     Document Type: Article

References (26)

1. Hening W.A. Restless legs syndrome: a sensorimotor disorder of sleep/wake motor regulation Curr Neurol Neurosci Rep 2 2002 186-196
2. Walters A.S. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group Mov Disord 10 1995 634-642
3. Allen R. Picchietti D. Hening W. et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health Sleep Med 4 2003 101-119
4. Hening W. Walters A.S. Wagner M. et al. Circadian rhythm of motor restlessness and sensory symptoms in the idiopathic restless legs syndrome Sleep 22 1999 901-912
5. Willis T. De animae brutorum 1672 Wells and Scott London
6. Ekbom K.A. Restless legs Acta Med Scand Suppl 158 1945 1-123
7. Allen R.P. Earley C.J. Restless legs syndrome: a review of clinical and pathophysiologic features J Clin Neurophysiol 18 2001 128-147
8. Phillips B. Young T. Finn L. et al. Epidemiology of restless legs symptoms in adults Arch Intern Med 160 2000 2137-2141
9. Ulfberg J. Nystrom B. Carter N. Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms Mov Disord 16 2001 1159-1163
10. Ulfberg J. Nystrom B. Carter N. Edling C. Restless legs syndrome among working-aged women Eur Neurol 46 2001 17-19
11. Lichstein K.L. Durrence H.H. Taylor D.J. et al. Quantitative criteria for insomnia Behav Res Ther 41 2003 427-445
12. Nichols D.A. Kushida C. Allen R. et al. Validation of RLS diagnostic questions in a primary care practice [abstract] Sleep 26 2003 A346
13. Ohayon M.M. Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population J Psychosom Res 53 2002 547-554
14. Montplaisir J. Boucher S. Poirier G. et al. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria Mov Disord 12 1997 61-65
15. Banno K. Delaive K. Walld R. Kryger M.H. Restless legs syndrome in 218 patients: associated disorders Sleep Med 1 2000 221-229
16. Rothdach A.J. Trenkwalder C. Haberstock J. et al. Prevalence and risk factors of RLS in an elderly population. The MEMO study Neurology 54 2000 1064-1068
17. Chesson A.L. Wise M. Davila D. et al. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine Sleep 22 1999 961-968
18. Standards of Practice Committee of the American Academy of Sleep Medicine Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine report Sleep 27 2004 557-559
19. Trenkwalder C. Stiasny K. Pollmacher T. et al. L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial Sleep 18 1995 681-688
20. Walters A.S. Hening W.A. Kavey N. et al. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome Ann Neurol 24 1988 455-458
21. Montplaisir J. Nicolas A. Denesle R. Gomez-Mancilla B. Restless legs syndrome improved by pramipexole: a double-blind randomized trial Neurology 52 1999 938-943
22. Wetter T.C. Stiasny K. Winkelmann J. et al. A randomized controlled study of pergolide in patients with restless legs syndrome Neurology 52 1999 944-950
23. Garcia-Borreguero D. Montagna P. Trenkwalder C. on behalf of the Ropinirole 190 Study Group Ropinirole is effective in the treatment of restless legs syndrome (RLS): a double-blind placebo-controlled 12-week study conducted in 10 countries [abstract] Neurology 60 Suppl 1 2003 A11-A12
24. Walters A.S. Ondo W. Sethi K. Dreykluft T. Grunstein R. Ropinirole versus placebo in the treatment of restless legs syndrome (RLS): a 12-week multicenter double-blind placebo-controlled study conducted in 6 countries [abstract] Sleep 26 2003 A344
25. Allen R. Becker P.M. Bogan R. et al. Restless legs syndrome: the efficacy of ropinirole in the treatment of RLS patients suffering from periodic leg movements of sleep [abstract] Sleep 26 2003 A341
26. Allen R.P. Earley C.J. Augmentation of the restless legs syndrome with carbidopa/levodopa Sleep 19 1996 205-213